针对细胞衰老作为胃癌的治疗漏洞
Haigang Geng1, Chen Huang1, Lei Xu2
1Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Life sciences
|April 15, 2024
概括
这项研究开发了一种胃癌特异性衰老评分 (GSS),以确定潜在的癌症治疗方法. 高GSS表明预后不佳和免疫抑制性瘤微环境,而exisulind在逆转GSS方面显示出希望.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 细胞衰老 (CS) 是对应激的细胞内防御机制,对癌症治疗具有潜在的脆弱性.
- 胃癌 (GC) 仍然是一个重大的健康挑战,需要新的治疗策略.
研究的目的:
- 为胃癌 (GC) 构建一个全面的细胞衰老地图.
- 通过准细胞衰老来确定GC的潜在治疗方法.
主要方法:
- 开发了胃癌特定的衰老评分 (GSS),使用来自CellAge数据库的38个衰老相关调节剂.
- 在CMap数据库中使用GSS通过 eXtreme Sum算法重新定位药物.
- 进行了体外实验,以评估palbociclib和exisulind在消除GC细胞中的组合.
主要成果:
- 高GSS与CS标记,不良临床结果和GC患者的低甲基化相关.
- 具有高GSS的恶性细胞表现出增强的衰老和免疫抑制信号,有助于免疫治疗耐药性.
- 埃克西苏林在与palbociclib.lib.结合使用时,在衰老的GC细胞中显示出逆转GSS和诱导亡的最高潜力.
结论:
- GSS为理解衰老和GC之间的相互作用提供了一个框架.
- 这些发现为开发针对GC细胞衰老的新疗法提供了新的见解.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


